Valuation: Hugel, Inc.

Market Cap 2,955B 2.1B 1.81B 1.69B 1.55B 2.92B 200B 2.97B 19.87B 7.8B 100B 7.87B 7.7B 331B P/E 2026 *
19.4x
P/E 2027 * 15.2x
Enterprise Value 2.4B 1.7M 1.47M 1.37M 1.26M 2.37M 162M 2.41M 16.11M 6.32M 81.09M 6.38M 6.24M 268M EV / Sales 2026 *
4.56x
EV / Sales 2027 * 3.52x
Free-Float
45.22%
Yield 2026 *
-
Yield 2027 * -
1 day-1.97%
1 week+17.63%
Current month+17.63%
1 month+15.89%
3 months-6.17%
6 months+10.06%
Current year+18.66%
1 week 241,000
Extreme 241000
295,000
1 month 216,500
Extreme 216500
295,000
Current year 216,500
Extreme 216500
308,500
1 year 208,500
Extreme 208500
361,000
3 years 106,400
Extreme 106400
392,000
5 years 99,700
Extreme 99700
392,000
10 years 75,865.91
Extreme 75865.908
392,000
Manager TitleAgeSince
Director of Finance/CFO 61 -
Chief Tech/Sci/R&D Officer 54 -
Chief Executive Officer 49 -
Director TitleAgeSince
Director/Board Member 54 29/04/2022
Director/Board Member 56 29/04/2022
Director/Board Member 51 29/04/2022
Date Insider Type Main position Quantity % Market Cap.
20/05/25 Fiscal year 1,200 0.0095%
20/05/25 Sell 1,200 0.0095%
19/05/25 Fiscal year

Chairman

31,510 0.2500%
Change 5-day change 1-year change 3-year change Capi.($)
-1.97%+17.63%-23.82%+153.24% 2.1B
+1.59%+2.85%+39.32%-0.16% 78.32B
+2.77%+4.78%-0.98%+26.82% 51.1B
+1.48%+2.30%+21.38%+178.26% 49.18B
+1.72%+8.18%-49.03%-49.18% 44.71B
+0.80%+2.46%+59.13%-23.35% 30.72B
+1.84%+0.87%+53.80%+84.29% 24.44B
+9.86%+7.94%+126.53%-41.89% 23.62B
+2.58%+13.14%+8.17%+202.17% 21.05B
-0.04%+3.85%+65.86%+115.82% 16.61B
Average +1.89%+5.11%+30.04%+64.60% 34.18B
Weighted average by Cap. +1.84%+4.35%+26.99%+43.23%

Financials

2026 *2027 *
Net sales 526B 373M 323M 301M 276M 520M 35.5B 528M 3.53B 1.39B 17.79B 1.4B 1.37B 58.82B 639B 454M 392M 366M 336M 632M 43.17B 642M 4.3B 1.69B 21.64B 1.7B 1.67B 71.53B
Net income 171B 121M 105M 97.89M 89.8M 169M 11.53B 172M 1.15B 451M 5.78B 455M 445M 19.11B 220B 156M 135M 126M 116M 217M 14.85B 221M 1.48B 580M 7.44B 586M 573M 24.6B
Net Debt -559B -396M -343M -320M -294M -552M -37.72B -561M -3.76B -1.47B -18.91B -1.49B -1.46B -62.51B -705B -500M -432M -404M -370M -697M -47.58B -708M -4.74B -1.86B -23.85B -1.88B -1.84B -78.83B
Logo Hugel, Inc.
Hugel Inc is a Korea-based company mainly engaged in the manufacture and sale of biopharmaceutical products. The Company is mainly engaged in the research, development, manufacturing, and sales of biopharmaceuticals utilizing type A botulinum toxin derived from the microorganism clostridium botulinum, as well as hyaluronic acid–based tissue‑restoration biomaterial filler products. In addition, the Company sells botulinum toxin products, hyaluronic acid fillers, cosmetics, skin boosters, and lifting threads. The Company distributes its products in domestic and overseas markets.
Employees
604
Date Price Change Volume
07/08/26 ₩273,500.00 -1.97% 96,138
06/08/26 ₩279,000.00 +7.31% 123,618
05/08/26 ₩260,000.00 +0.78% 38,984
04/08/26 ₩258,000.00 +7.95% 50,802
03/08/26 ₩239,000.00 +2.80% 34,152
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
273,500.00KRW
Average target price
369,312.50KRW
Spread / Average Target
+35.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A145020 Stock